tiprankstipranks
ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
US Market

ArriVent BioPharma, Inc. (AVBP) Stock News & Sentiment

Compare
26 Followers
Premium
Company Announcements
ArriVent BioPharma Reports 2024 Financial Results and Progress
2d ago
Premium
Ratings
Buy Rating for ArriVent BioPharma: Promising Clinical Developments and Strategic Progress in NSCLC Treatment
3d ago
Premium
Company Announcements
ArriVent BioPharma Expands Oncology Pipeline with New License
1M ago
Premium
Company Announcements
ArriVent BioPharma Advances Cancer Therapeutics Pipeline
4M ago
Premium
Company Announcements
ArriVent BioPharma’s Strategic Alliance for Cancer Drug Development
9M ago
Premium
Company Announcements
ArriVent BioPharma Welcomes Dr. Hohneker to Board
10M ago
Premium
Company Announcements
ArriVent BioPharma Welcomes Kristine Peterson to Board
11M ago
More AVBP News >

News Score - Last 7 Days

Neutral
AVBP
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AVBP’s Media Buzz Sentiment?
Currently, no data Available
What is AVBP’s weekly average amount of articles?
Currently, no data Available
What is AVBP’s News Sentiment?
50% of articles about AVBP were positive this week, compared to its sector average of 59%.
    General Stocks that are Trending in the News
    ADA-USDCardano
    APT-USDAptos
    HBAR-USDHedera
    CRO-USDCronos
    NXTNext Geosolutions Europe SpA
    Showing the stocks with the most bullish news sentiment over the past week
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis